Document Detail

Cis-platinum(II) diamine dichloride causes mutation, transformation, and sister-chromatid exchanges in cultured mammalian cells.
MedLine Citation:
PMID:  440327     Owner:  NLM     Status:  MEDLINE    
The anti-tumor agent cis-platinum(II) diamine dichloride caused dose-dependent toxicity in V79 Chinese hamster cells and in secondary Syrian hamster embryo cells. Chromosome aberrations were induced and positive dose--response relationships were observed for induction of sister-chromatid exchanges and 6-thioguanine-resistant mutations in V79 cells and morphologic transformation of secondary Syrian hamster embryo cells. The findings suggest that this chemical is a potential human carcinogen.
D Turnbull; N C Popescu; J A DiPaolo; B C Myhr
Related Documents :
9042397 - Mismatch repair provokes chromosome aberrations in hamster cells treated with methylati...
1081977 - Dip and dip+2 as glutathione oxidants and radiation sensitizers in cultured chinese ham...
7543357 - Ionophoretically applied substance p activates hamster suprachiasmatic nucleus neurons.
460287 - Effect of cell growth rate and dose fractionation on chemically-induced ouabain-resista...
23339867 - Phosphate-activated cyclin-dependent kinase stabilizes g1 cyclin to trigger cell cycle ...
2272117 - Methotrexate: studies on cellular metabolism. iv. effect on the mitochondrial oxidation...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Mutation research     Volume:  66     ISSN:  0027-5107     ISO Abbreviation:  Mutat. Res.     Publication Date:  1979 Mar 
Date Detail:
Created Date:  1979-07-16     Completed Date:  1979-07-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0400763     Medline TA:  Mutat Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  267-75     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Line
Chromosome Aberrations*
Chromosomes / drug effects*
Cisplatin / pharmacology*
Crossing Over, Genetic
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Embryo, Mammalian
Reg. No./Substance:
0/Mutagens; 15663-27-1/Cisplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Increased frequencies of aberrant sperm as indicators of mutagenic damage in mice.
Next Document:  Private cost containment.